RENOVARO BIOSCIENCES INC. - Annual Reports and 10-K Forms

Pharmaceutical Preparations

Company is also known as: Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.

Market tickers: RENB (Nasdaq)

Annual Reports list

Annual report 2022 (10-K 2022-06-30)

Annual report 2021 (10-K 2021-06-30)

Annual report 2020 (10-K 2020-06-30)

Annual report 2019 (10-K 2019-06-30)

Annual report 2018 (10-K 2018-06-30)

Annual report 2017 (10-K 2017-06-30)

Annual report 2016 (10-K 2016-06-30)

Annual report 2014 (10-K 2014-12-31)

Annual report 2013 (10-K 2013-03-31)

Annual report 2012 (10-K 2012-03-31)

Annual report 2023 (10-K 2023-06-30)

Quarter Reports list

Annual report 2022 (10-Q 2022-12-31)

Annual report 2022 (10-Q 2022-09-30)

Annual report 2022 (10-Q 2022-03-31)

Annual report 2021 (10-Q 2021-12-31)

Annual report 2021 (10-Q 2021-09-30)

Annual report 2021 (10-Q 2021-03-31)

Annual report 2020 (10-Q 2020-12-31)

Annual report 2020 (10-Q 2020-09-30)

Annual report 2020 (10-Q 2020-03-31)

Annual report 2019 (10-Q 2019-12-31)

Annual report 2019 (10-Q 2019-09-30)

Annual report 2019 (10-Q 2019-03-31)

Annual report 2018 (10-Q 2018-12-31)

Annual report 2018 (10-Q 2018-09-30)

Annual report 2018 (10-Q 2018-03-31)

Annual report 2017 (10-Q 2017-12-31)

Annual report 2017 (10-Q 2017-09-30)

Annual report 2017 (10-Q 2017-03-31)

Annual report 2016 (10-Q 2016-12-31)

Annual report 2016 (10-Q 2016-09-30)

Annual report 2016 (10-Q 2016-03-31)

Annual report 2015 (10-Q 2015-12-31)

Annual report 2015 (10-Q 2015-09-30)

Annual report 2015 (10-Q 2015-03-31)

Annual report 2014 (10-Q 2014-09-30)

Annual report 2014 (10-Q 2014-06-30)

Annual report 2014 (10-Q 2014-03-31)

Annual report 2013 (10-Q 2013-12-31)

Annual report 2013 (10-Q 2013-09-30)

Annual report 2013 (10-Q 2013-06-30)

Annual report 2012 (10-Q 2012-12-31)

Annual report 2012 (10-Q 2012-09-30)

Annual report 2012 (10-Q 2012-06-30)

Annual report 2011 (10-Q 2011-12-31)

Annual report 2011 (10-Q 2011-09-30)

Annual report 2023 (10-Q 2023-03-31)

Annual report 2023 (10-Q 2023-09-30)